"The Lynn Institute is one of the nation’s most respected clinical trial organizations. We evaluate the latest scientific findings in medications, systems, and treatment models designed to improve the quality of human life."

During the past decade, Lynn Institute of the Rockies conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 18 clinical trials were completed, i.e. on average, 180% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynn Institute of the Rockies" #1 sponsor was "Pfizer" with 5 trials, followed by "Sucampo Pharma Americas, LLC" with 2 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Bausch Health Americas, Inc." with 1 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynn Institute of the Rockies" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Lynn Institute of the Rockies" are "Osteoarthritis" (3 trials), "Cardiovascular Disease" (2 trials), "Irritable Bowel Syndrome" (2 trials), "Meningococcal Vaccines" (2 trials) and "Opioid-Induced Bowel Dysfunction" (2 trials). Many other conditions were trialed in "Lynn Institute of the Rockies" in a lesser frequency.

Most popular intervention types in "Lynn Institute of the Rockies" are "Drug" (22 trials), "Biological" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Naproxen" (2 trials), "bococizumab (PF-04950615)" (2 trials), "1% SPL7013 Gel" (1 trials) and "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lynn Institute of the Rockies" are 26 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lynn Institute of the Rockies". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Lynn Institute of the Rockies, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lynn Institute of the Rockies, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".